Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: bioequivalence

December 14, 2020 Events / Pharma applications

International Conference on Advances in Pharmaceutical Drug Development, Quality Control and Regulatory Sciences (DDRS 2021)

Keeping participants’ safety in focus, a survey was conducted among our participants, speakers and sponsors to learn about their preference

Continue reading

March 14, 2020 Events / Pharma applications

Postponed: International Conference on Advances in Pharmaceutical Drug Development, Quality Control and Regulatory Sciences (DDRS 2020)

As one of Europe’s most prestigious drug research conferences, the International Conference on Advances in Pharmaceutical Drug Development, Quality Control

Continue reading

October 21, 2019 Events / Pharma applications

International Conference on Advances in Pharmaceutical Drug Development, Quality Control and Regulatory Sciences (DDRS 2020)

As one of Europe’s most prestigious drug research conferences, the International Conference on Advances in Pharmaceutical Drug Development, Quality Control

Continue reading

September 24, 2018 Drug delivery / Pharma applications

Cyclodextrins in oral formulations – has the time of supergenerics come?

Development of generic formulations with cyclodextrins for oral delivery has been neglected for several decades, since the CD-enabled formulations often

Continue reading

Recent Posts

  • Association of Sugammadex Exposure with Venous Thrombosis Risk Following Primary Total Knee Arthroplasty: A Multi-Institutional Retrospective Analysis
  • Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition”
  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
  • REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (73)
  • CD as API (356)
  • CD derivatives (431)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (816)
  • E-ducation (63)
  • Environmental (143)
  • Events (239)
  • Food (233)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (45)
  • Non-pharma applications (416)
  • Other industrial use (112)
  • Pharma applications (1,220)
  • Supramolecular systems (44)
  • Uncategorized (167)

Top Posts

  • REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition
  • Association of Sugammadex Exposure with Venous Thrombosis Risk Following Primary Total Knee Arthroplasty: A Multi-Institutional Retrospective Analysis
  • Two ways for manufacturing CD fibres
  • Revolutionary Nanozyme Microneedles for Gout Treatment
  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
  • A Cyclodextrin Surprise in a Japanese Supplement
  • Beyond Cholesterol: New Review Examines 7-Ketocholesterol and Its Role in Disease
  • Japanese Breakthrough Science: Enzyme-Degradable Recyclable Plastic Reinforced with Movable Cyclodextrin Crosslinks
  • Strategies against antifungal resistance

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...